DOI QR코드

DOI QR Code

Concealed congenital long QT syndrome during velopharyngeal dysfunction correction: a case report

  • Jeon, Soeun (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Lee, Hyeon-Jeong (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Jung, Young-hoon (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Do, Wangseok (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Cho, Ah-Reum (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Baik, Jiseok (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Lee, Do-Won (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Kim, Eun-Jung (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute) ;
  • Kim, Eunsoo (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) ;
  • Hong, Jeong-Min (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University)
  • Received : 2020.04.08
  • Accepted : 2020.05.12
  • Published : 2020.06.30

Abstract

The congenital long QT syndrome (LQTS) is an inherited cardiac disorder characterized by increased QT intervals and a tendency to experience ventricular tachycardia, which can cause fainting, heart failure, or sudden death. A 4-year-old female patient undergoing velopharyngeal correction surgery under general anesthesia suddenly developed Torsades de pointes. Although the patient spontaneously resolved to sinus rhythm without treatment, subsequent QT prolongation persisted. Here, we report a case of concealed LQTS with a literature review.

Keywords

References

  1. Bohnen MS, Peng G, Robey SH, Terrenoire C, Iyer V, Sampson KJ, et al. Molecular pathophysiology of congenital long QT syndrome. Physiol Rev 2017; 97: 89-134. https://doi.org/10.1152/physrev.00008.2016
  2. Booker PD, Whyte SD, Ladusans EJ. Long QT syndrome and anaesthesia. Br J Anaesth 2003; 90: 349-66. https://doi.org/10.1093/bja/aeg061
  3. Fazio G, Vernuccio F, Grutta G, Re GL. Drugs to be avoided in patients with long QT syndrome: focus on the anaesthesiological management. World J Cardiol 2013; 5: 87-93. https://doi.org/10.4330/wjc.v5.i4.87
  4. Alders M, Bikker H, Christiaans I. Long QT Syndrome [serial on the Internet]. 2018 Feb [2018 Feb 8]. Available from http://www.ncbi.nlm.nih.gov/books/NBK1129/
  5. Kies SJ, Pabelick CM, Hurley HA, White RD, Ackerman MJ. Anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005; 102: 204-10. https://doi.org/10.1097/00000542-200501000-00029
  6. Crotti L, Celano G, Dagradi F, Schwartz PJ. Congenital long QT syndrome. Orphanet J Rare Dis 2008; 3:18. https://doi.org/10.1186/1750-1172-3-18
  7. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. an update. Circulation 1993; 88: 782-4. https://doi.org/10.1161/01.CIR.88.2.782
  8. O'Hare M, Maldonado Y, Munro J, Ackerman MJ, Ramakrishna H, Sorajja D. Perioperative management of patients with congenital or acquired disorders of the QT interval. Br J Anaesth 2018; 120: 629-44. https://doi.org/10.1016/j.bja.2017.12.040
  9. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102: 1178-85. https://doi.org/10.1161/01.CIR.102.10.1178
  10. Vyas H, Ackerman MJ. Epinephrine QT stress testing in congenital long QT syndrome. J Electrocardiol 2006; 39(4 Suppl): S107-13. https://doi.org/10.1016/j.jelectrocard.2006.05.013
  11. Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004; 1: 276-83. https://doi.org/10.1016/j.hrthm.2004.04.021
  12. Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR, et al. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science 2002; 295: 496-9. https://doi.org/10.1126/science.1066843
  13. Clur SA, Chockalingam P, Filippini LH, Widyanti AP, van Cruijsen M, Blom NA, et al. The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome. Pediatr Cardiol 2010; 31: 462-8. https://doi.org/10.1007/s00246-009-9603-2
  14. International Council of Harmonization (ICH) Harmonised Tripartite Guideline. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs E14 [serial on the Internet]. 2005 May. Available from https://fossaconsulting.com/wp-content/uploads/2016/08/ae361d1b023c176a97a14030f4063b39.pdf.
  15. Abe K, Takada K, Yoshiya I. Intraoperative torsade de pointes ventricular tachycardia and ventricular fibrillation during sevoflurane anesthesia. Anesth Analg 1998; 86: 701-2. https://doi.org/10.1213/00000539-199804000-00004
  16. Lustik SJ, Eichelberger JP, Chibber AK, Bronsther O. Torsade de pointes during orthoptic liver transplantation. Anesth Analg 1998; 87: 300-3. https://doi.org/10.1213/00000539-199808000-00011
  17. Medak R, Benumof JL. Perioperative management of the prolonged Q-T interval syndrome. Br J Anaesth 1983; 55: 361-4. https://doi.org/10.1093/bja/55.4.361
  18. Brown M, Liberthson RR, Ali HH, Lowenstein E. Perioperative anesthetic management of a patient with long Q-T syndrome (LQTS). Anesthesiology 1981; 55: 586-9. https://doi.org/10.1097/00000542-198111000-00020
  19. Saarnivaara L, Lindgren L. Prolongation of QT interval during induction of anaesthesia. Acta Anaesthesiol Scand 1983; 27:126-30. https://doi.org/10.1111/j.1399-6576.1983.tb01921.x
  20. Kumakura M, Hara K, Sata T. Sevoflurane-associated torsade de pointes in a patient with congenital long QT syndrome genotype 2. J Clin Anesth 2016; 33: 81-5. https://doi.org/10.1016/j.jclinane.2016.03.011
  21. Priori SG, Napolitano C, Schwartz PJ, Grillo M, Bloise R, Ronchetti E, et al. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004; 292: 1341-4. https://doi.org/10.1001/jama.292.11.1341
  22. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the americam college of cardiology/american heart association task force on clinical practice guidelines ande the heart rhythm society. Heart Rhythm 2018; 15: e190-252. https://doi.org/10.1016/j.hrthm.2017.10.035
  23. Atkins DL, Berger S, Duff JP, Gonzales JC, Hunt EA, Joyner BL, et al. Part 11: pediatric basic life support and cardiopulmonary resuscitation quality: 2015 american heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015; 132(18 Suppl 2): S519-25.
  24. Schwartz PJ, Spazzolini C, Crotti L. All LQT3 patients need an ICD: true or false? Heart Rhythm 2009; 6: 113-20. https://doi.org/10.1016/j.hrthm.2008.10.017
  25. Vincent GM, Schwartz PJ, Denjoy I, Swan H, Bithell C, Spazzolini C, et al. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures". Circulation 2009; 119: 215-21. https://doi.org/10.1161/CIRCULATIONAHA.108.772533
  26. Jons C, Moss AJ, Goldenberg I, Liu J, McNitt S, Zareba W, et al. Risk of fatal arrhythmic events in long QT syndrome patients after syncope. J Am Coll Cardiol 2010; 55: 783-8. https://doi.org/10.1016/j.jacc.2009.11.042